For citations:

Rudakova A.V., Meshkov D.O., Mishugin S.V. Cost-effectiveness of abiraterone treatment in patients with castration-resistant prostate cancer who previously received docetaxel therapy. Cancer Urology. 2014;10(3):73-77. (In Russ.) https://doi.org/10.17650/1726-9776-2014-10-3-73-77